Bharat Biotech's US partner Ocugen submits "Master File" to FDA on Covaxin

Ocugen has submitted key information and data to date including preclinical studies, chemistry, manufacturing, and controls (CMC), and clinical studies as a Master File for FDA review and input prior to a planned EUA submission.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Sq5rgq
via IFTTT